Soft Tissue - Updated 2022

FRCPath Course Soft Tissue Slide Seminar DR P Shenjere Consultant Histopathologist The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

Case 1 • 15M; Lesion LT cheek

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

SMA The Christie NHS Foundation Trust

DIAGNOSIS

The Christie NHS Foundation Trust

Case 10 • 19M; Neck mass

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

DIAGNOSIS

The Christie NHS Foundation Trust

Nodular Fasciitis (NF): • • • • •

Common in young adults(20 to 40yrs) Most lesions grow rapidly and then stabilize Sites – usually upper extremity, trunk, head and neck Size – usually 2-3cm, almost never more than 5cm Anatomically – subcutaneous, fascial or intramuscular and rarely dermal • Self limiting

The Christie NHS Foundation Trust

Nodular Fasciitis (NF):

• Circumscribed or infiltrative, unencapsulated • Plump spindle cells which lack nuclear pleomorphism • Markedly cellular, but focally shows loose, myxoid, torn, feathery

character. Formation of microcysts in some cases • Spindle cells form S- or C- shaped fascicles • Mitotic figures may be numerous but no atypical forms seen

• Extravasated RBC, mononuclear inflammatory cells and osteoclast-like GC – commonly seen

The Christie NHS Foundation Trust

NF (cont……): • Immuno-stains for SMA, MSA and calponin strongly positive; negative for desmin, CK, S100 protein, CD34 and h-Caldesmon.

CD68 stains the osteoclast-like GC as well as some spindle cells • EM – myofibroblasts and fibroblasts • Variants: Intravascular, cranial and ossifying fasciitis intradermal NF

The Christie NHS Foundation Trust

D/D of Nodular Fasciitis (NF) • • • • • • • •

Leiomyosarcoma Low grade myofibrosarcoma Low grade fibromyxoid sarcoma Low grade myxofibrosarcoma Myxoid DFSP Fibromatosis Benign fibrous histiocytoma Myxoma The Christie NHS Foundation Trust

• t(17;22(p13;q12.3) -cryptic • USP6-MYH9 • •

a deubiquitinating protease involved in cell trafficking, protein degradation, signalling, and inflammation novel fusion gene partners are RRBP1, CALU, MIR22HG, SPARC, THBS2, COL6A2 and CTNNB1

• • • •

Myositis ossificans Cellular fibroma of tendon sheath Fibro-osseous pseudotumour of digits (ABC) The Christie NHS Foundation Trust

Case 7 • 28F; vocal cord lesion

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

ALK 1 The Christie NHS Foundation Trust

DIAGNOSIS

The Christie NHS Foundation Trust

Diagnosis • Inflammatory Myofibroblastic Tumour

The Christie NHS Foundation Trust

Inflammatory myofibroblastic tumour(IMT) • Mostly affect children and young adults • Common sites – lung, mesentery and omentum. Other sites – soft tissue, viscera, oral cavity and URT, GIT, GUT, breast and CNS • Systemic symptoms, anaemia, fever, polyclonal hypergammaglobulinaemia and raised ESR in some cases (probably related to IL-6 production) • Solitary or multinodular/multifocal

The Christie NHS Foundation Trust

Inflammatory myofibroblastic tumour • Size varies from 1 to 20cm • macro: firm and fleshy; may contain gelatinous areas with foci of hmg • Composed of a mixture of myofibroblasts, fibroblasts and mostly mononuclear inflammatory cells(B & T lymphocytes and polyclonal plasma cells). Compact fascicular or storiform growth pattern in cellular areas • Lymphoid follicles with germinal centres in some lesions • Large numbers of blood vessels mimicking granulation tissue may be seen • Variable myxoid and collagenized areas

The Christie NHS Foundation Trust

IMT • • •

•

•

Ganglion-like myofibroblasts may be seen Calcification and metaplastic bone rarely seen Three patterns have been described, the first mimicking NF, the second LGMFS or LMS, and the third fibromatosis Epithelioid inflammatory myofibroblastic sarcoma is an aggressive IMT subtype Frank malignant transformation in rare cases

The Christie NHS Foundation Trust

IMT • • • •

80-90% SMA +ve Desmin and calponin focally +ve in 60-70% 1/3 +ve for CK ALK +ve in 50-60%; positivity reliably predicts the presence of ALK gene rearrangement (Alk gene rearrangement can be detected by FISH) • 10% show ROS-1or NTRK3 rearrangement • Rare cases show RET or PDGFB gene rearrangements

The Christie NHS Foundation Trust

ALK Dual Colour Break Apart Probe; Abnormal Result

Key; Red/Green Fusion Signal = Normal ALK gene.

Red (3’) & Green (5’) signals flank the ALK breakpoint cluster region.

The separate red and green signals indicate a Rearrangement of ALK

The Christie NHS Foundation Trust

D/D of IMT • • • • • • • • •

NF Fibromatosis LGMFS Leiomyosarcoma SFT GIST FDRCT Retroperitoneal fibrosis Sarcomatoid carcinoma (in CK positive cases)

The Christie NHS Foundation Trust

Case 23 • 27F; Abdominal wall mass

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

SMA

The Christie NHS Foundation Trust

DIAGNOSIS • Fibromatosis D/D • • • • • • • •

NF Desmoplastic fibroblastoma Perineurioma SFT LGMFS LGFMS LG-MPNST FS The Christie NHS Foundation Trust

• 90–95% of sporadic desmoid tumours have one of 3 point mutations in two codons (41 and 45) of exon 3 CTNNB1 gene: p.Thr41Ala, p.Ser45Pro, and p.Ser45Phe • Smaller percentage of tumours arise in the setting of Gardner syndrome - pts harbour germline mutations in the APC tumour suppressor gene ß-CATENIN

The Christie NHS Foundation Trust

Case 20 • 59M; vocal cord lesion

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

AE1/3 The Christie NHS Foundation Trust

34BE12 The Christie NHS Foundation Trust

p63 The Christie NHS Foundation Trust

SMA The Christie NHS Foundation Trust

DIAGNOSIS

The Christie NHS Foundation Trust

Spindle Cell Carcinoma • Also called sarcomatoid carcinoma • M>F • Associated with drinking, smoking and previous radiotherapy treatment • Usually situated in the glottic region

The Christie NHS Foundation Trust

Macroscopy & Histology • Polypoid lesion • Usually ulcerated • Biphasic – sarcomatoid/spindle cell component & squamous cell component • Sarcomatoid component consist of spindle cells arranged in different patterns such as fascicles, myxoid, storiform etc • Foci of chondrosarcomatous/rhabdomyosarcomatous differentiation may be present • Neoplastic squamous component present in upto 81% - Either as an in-situ or invasive component

The Christie NHS Foundation Trust

IHC • CK +ve – broad spectrum ck e.g MNF116 & AE1/3, HMW CKs • p63 • Mesenchymal markers +ve in the sarcomatoid component

The Christie NHS Foundation Trust

Differential Diagnosis • Benign spindle cell lesions• Nodular fasciitis, ossifying & non ossifying fibro-osseous lesions, vocal cord nodule with stromal atypia, laryngeal contact ulcer/ granulation tissue, • SarcomasMPNST, synovial sarcoma,leiomyosarcoma, IMT, SFT, KS, etc • Spindle cell melanoma • Spindle cell myoepithelioma

The Christie NHS Foundation Trust

Case 4 • 62F; Perineal tumour

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

CD34

BCL2 The Christie NHS Foundation Trust

DIAGNOSIS

The Christie NHS Foundation Trust

Solitary Fibrous Tumour • • • • • •

CD34 (95%) CD99 BCL2 EMA (33%) SMA (33%) Some cases may show focal S100, CK or desmin positivity

The Christie NHS Foundation Trust

SFT • NAB2-STAT6 gene fusion • inv(12)(q13q13) •

NAB2 exon 4 – STAT6 exon3 & NAB2 exon 6 – STAT6 exon 17 most common fusion variants

• Other fusion gene reported: STAT6- TRAPPC5 • Overexpression of STAT6

The Christie NHS Foundation Trust

Solitary Fibrous Tumour • • • • • •

CD34 (95%) CD99 BCL2 EMA (33%) SMA (33%) Some cases may show focal S100, CK or desmin positivity • STAT6

STAT6

The Christie NHS Foundation Trust

3&4-variable risk stratification models for prediction of metastatic potential in SFTs – modified from WHO Classification of tumours series, 2020

Risk Factor

Score (3 variable model)

Score(4 variable model)

Age 55 ≥55

0 1

0 1

Tumour size (cm) <5 5 to 9.9 10 to 14.9 ≥15

0 1 2 3

0 1 2 3

Mitoses per mm2 (/10 HPF) 0 (0) 0.5-1.5(1–3) ≥2 (≥4)

0 1 2

0 1 2

Tumour necrosis <10% ≥10%

N/A N/A

0 1

Risk category Low Intermediate High

Total Score 0-2 3-4 5-6

Total Score 0-3 4-5 6-7

hTERT promoter and/or TP53 mutations ass. with aggressive behaviour Demicco et al, Mod Pathol. 2012 & 2017

“Dedifferentiated” SFT

The Christie NHS Foundation Trust

SFT Differential diagnosis • Sarcomatoid mesothelioma • Sarcomatoid carcinoma • Synovial sarcoma • Dedifferentiated LPS • Low grade fibromyxoid sarcoma • Cellular schwannoma • MPNST The Christie NHS Foundation Trust

Case 8 • 29F; Thigh mass

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

DIAGNOSIS

The Christie NHS Foundation Trust

Monophasic Synovial Sarcoma

The Christie NHS Foundation Trust

IHC • Most cases show positivity for CK and EMA • EMA expressed more often and more widely • EMA consistently +ve in epithelial elements of biphasic SS • Other markers- TLE1 (85-97%), CD99 • Focal positivity for S100 in ≈40% • CD34 positivity – very rare

The Christie NHS Foundation Trust

Synovial Sarcoma • SS18 (18q11.2) • SSX (Xp11.21-23) types 1, 2, 4 (of 5)

• SS18/SSX fusion genes 60% SSX1, 40% SSX2,<1% SSX4 •

Rare variants e.g. t(X;20)(p11.23;q13.33) (SS18L1-SSX)

•

(SS18L1-SSX)

•Ladanyi 2002; Allander 2002; Guillou 2004; Baird 2005; Storlazzi 2007; Amary 2007; Nakayama 2007

The Christie NHS Foundation Trust

D/D • • • • •

Fibrosarcoma Leiomyosarcoma Clear cell sarcoma Fibromatosis carcinoma

The Christie NHS Foundation Trust

Biphasic SS

The Christie NHS Foundation Trust

Poorly Differentiated SS

The Christie NHS Foundation Trust

Hemangiopericytic Growth Pattern Stout & Murray: “Hemangiopericytoma: a vascular tumor featuring Zimmerman’s pericytes” Annals of Surgery, 1942.

The Christie NHS Foundation Trust

Tumours with Haemangiopericytic Pattern • • • • • •

SFT Myofibroma Synovial sarcoma Mesenchymal chondrosarcoma Some MPNST ESS

The Christie NHS Foundation Trust

Case 27 • 35M; Shoulder lesion

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

IHC • Diffusely positive for CD34

The Christie NHS Foundation Trust

DIAGNOSIS • DFSP

The Christie NHS Foundation Trust

Dermatofibrosarcoma Protuberans (DFSP) • • • • •

Dermal and subcutaneous tumour Atrophic epidermis Cytologically bland and uniform Prominent storiform pattern Lace-like or honeycomb pattern of infiltration of subcutaneous fat • Infiltrates along septa of adipose tissue • Rarely has giant cell fibroblastoma component

The Christie NHS Foundation Trust

IHC • Diffusely positive for CD34 • Rare examples –ve for CD34 • SMA+/Other superficial spindle cell tumours +ve for CD34: 1.

2.

3.

4.

5.

6.

Myxoinflammatory fibroblastic sarcoma Cellular angiofibroma Superficial acral fibromyxoma Spindle cell lipoma SFT Mammary type myofibroblastoma The Christie NHS Foundation Trust

Morphological Variants • Pigmented (Bednar tumour) • Myxoid • Granular cell and atrophic variants also described

Myxoid DFSP

The Christie NHS Foundation Trust

Occasionally contain myoid whorls/bodies

CD34

SMA The Christie NHS Foundation Trust

DFSP with Fibrosarcomatous Transformation

• DFSP rarely undergoes fibrosarcomatous change (<5%) • Occur de novo or in recurrences • Gradual or abrupt • Cellular with associated nuclear atypia, increased mitoses • Cells arranged in fascicles producing a herringbone pattern • 10-15% metastasise The Christie NHS Foundation Trust

DFSP Molecular Pathology • t(17;22)(q22;q13) - most common • Supernumerary ring chromosomes containing material from 17q22 and 22q13 → fusion of COL1a1 and PDGFβ Fusion protein processed into functional PDGF-β

The Christie NHS Foundation Trust

When is FISH Required?

• Not in classical cases • Useful in unusual histologic patterns & in cases with fibrosarcomatous transformation & metastases • Small punch biopsies

The Christie NHS Foundation Trust

Tumours with a storiform growth pattern • Other fibrohistiocytic tumours (BFH, PDS/pleomorphic undifferentiated sarcoma) • Perineurioma • Occasional cases of MPNST • Occasional cases of spindle cell carcinoma • Some cases of SFT • Nodular Fasciitis

The Christie NHS Foundation Trust

Case 6 • 52F; Thigh lesion

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

CD34 CD34

The Christie NHS Foundation Trust

DIAGNOSIS • Benign Fibrous Histiocytoma

The Christie NHS Foundation Trust

Benign Fibrous Histiocytoma • PRKCB-PDPN t(1;16)(p36;p11) • PRKCD-LAMTOR1 t(3;12)(p21;q13) • PRKCD-RDH5 t(3;12)(p21;q13)

The Christie NHS Foundation Trust

Case 11 • 33F; Middle finger lesion

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

DIAGNOSIS

The Christie NHS Foundation Trust

Atypical Fibrous Histiocytoma • Extremities of young patients, non sun damaged skin • Low power view resembles ordinary BFH • High power view reveals foci of severe cytological atypia, high mitotic count, necrosis • Characterised by frequent local recurrence, rare mets • Rx- complete excision and follow up

The Christie NHS Foundation Trust

D/D • • • • • •

BFH AFX Spindle cell Ca Leiomyosarcoma Melanoma Spindle cell Sarcoma NOS (MFH)

The Christie NHS Foundation Trust

Variants of FH • • • •

Cellular Aneurysmal Atypical Deep

• • • • • • • • •

Epithelioid fibrous histiocytoma Clear Cell Granular cell Keloidal Lipidized Atrophic Myxoid Palisading Myofibroblastic

The Christie NHS Foundation Trust

Case 25 • 80M; Scalp lesion

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

IHC • +ve for CK14, CK5, p63 • No mucin on PAS

The Christie NHS Foundation Trust

DIAGNOSIS • Spindle cell carcinoma/sarcomatoid carcinoma

The Christie NHS Foundation Trust

Case 19 • 70M; Forehead lesion

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

Negative for: CK, CD34, ERG, SMA, Desmin, S100, SOX10.

The Christie NHS Foundation Trust

DIAGNOSIS

The Christie NHS Foundation Trust

Diagnosis • Pleomorphic dermal sarcoma • Not AFX because of subcutaneous extension, and necrosis • LVI and PNI also preclude the dx of AFX

The Christie NHS Foundation Trust

Case 22 • 69M; Forehead lesion

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

CD34

CD31 ERG

The Christie NHS Foundation Trust

DIAGNOSIS

The Christie NHS Foundation Trust

Angiosarcoma (AS) • Conventional (idiopathic) • Lymphoedema assoc.

• Post radiation Conventional AS • • • •

Elderly pts Sun-damaged skin Head & neck M>F

The Christie NHS Foundation Trust

Epithelioid AS

The Christie NHS Foundation Trust

Epithelioid AS

CD31

The Christie NHS Foundation Trust

Clear Cell/Signet Ring Cell AS

Am. J. Dermatopathol.2013; 35; 671–675 Histopathology 2015, 66, 856–863

The Christie NHS Foundation Trust

Clear Cell/Signet Ring Cell AS

The Christie NHS Foundation Trust

Other Morphological Variants of Epithelioid AS • Foamy cell • Granular cell

Dermatopathol. 2014; 36; 669–672 J. Cutan. Pathol. 2010; 37; 901–906 J. Cutan. Pathol. 2012; 39; 476–478, 475

Histopathology 2015, 66, 856–863

The Christie NHS Foundation Trust

AS • Can be mostly epithelioid/spindled • Vasoformation can be inconspicuous, usually seen at the periphery • Can be easily mistaken for other tumours if index of suspicion low!

The Christie NHS Foundation Trust

AS IHC • Use more than one endothelial marker • CD34, CD31, ERG, FVIIIRA, Fli-1, Podoplanin(D2-40) • CD31 – not entirely specific, also expressed by histiocytes, plasma cells etc • CD34 – less sensitive than CD31 & not specific • Fli-1 – poor specificity; expressed by carcinomas, AFX/PDS, MM

The Christie NHS Foundation Trust

ERG

CD31

ERG The Christie NHS Foundation Trust

D/D of cutaneous Spindle Cell Tumour with cellular pleomorphism • • • • • •

Atypical Fibroxanthoma (AFX) Spindle Cell Carcinoma Melanoma Leiomyosarcoma Angiosarcoma Atypical Fibrous Histiocytoma

The Christie NHS Foundation Trust

IHC in D/D of Pleomorphic Cutaneous Spindle Cell Tumours 34BE12

CK5

p40

SMA

Desmin

S100

CD31

ERG

SpCC +

+

+

+

+/-

-

-

-

-

AFX & PDS

-

-

-

-

-/+

-

-

-/+

-

AS

-/+

-

-

-

+

-

-

+

+

LMS

-/+

-

-

-

+

+

-

-

-

MM

-/+

-

-

-

+/-

-

+

-

-

Tumour

AE1/3 or MNF116

The Christie NHS Foundation Trust

Case 12 • 61M; Groin mass

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

SMA The Christie NHS Foundation Trust

DIAGNOSIS

The Christie NHS Foundation Trust

Intravascular Leiomyosarcoma • Most commonly involve IVC/PA D/D • Intimal sarcoma

The Christie NHS Foundation Trust

Case 17 • 31F; Bladder tumour

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

SMA

h-caldesmon Desmin The Christie NHS Foundation Trust

DIAGNOSIS • Leiomyosarcoma • Pt Rxd for retinoblastoma in childhood Ref: Soft tissue, pelvic, and urinary bladder leiomyosarcoma as second neoplasm following hereditary retinoblastoma.

Venkatraman L, Goepel JR, Steele K, Dobbs SP, Lyness RW, McCluggage WG. J Clin Pathol. 2003 Mar;56(3):233-6.

The Christie NHS Foundation Trust

Case 16 • 68F; Lt buttock lesion

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

S100 The Christie NHS Foundation Trust

DIAGNOSIS • Schwannoma

The Christie NHS Foundation Trust

Cystic change The Christie NHS Foundation Trust

Plexiform Schwannoma The Christie NHS Foundation Trust

Case 21 • 76M; Lt knee lesion

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

IHC • Dot-like paranuclear positivity for CK20 and CAM 5.2 • Positive for Chromogranin, Synaptophysin and NF • -ve for TTF-1 CK20

The Christie NHS Foundation Trust

DIAGNOSIS • Merkel cell Carcinoma

The Christie NHS Foundation Trust

D/D • • • • • •

Ewing sarcoma Lymphoma Small cell melanoma Metastatic small cell carcinoma Rhabdomyosarcoma Other SRBCTs - Sarcoma with BCOR genetic alterations, CIC- rearranged sarcoma etc

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

PAS+/-DIASTASE

The Christie NHS Foundation Trust

CD99 Synaptophysin S100

MNF116 Chrom A CD45 Tdt

The Christie NHS Foundation Trust

CD56 The Christie NHS Foundation Trust

DESMIN The Christie NHS Foundation Trust

Myo-D1

Myogenin

The Christie NHS Foundation Trust

Diagnosis • Rhabdomyosarcoma (solid variant of alveolar subtype)

The Christie NHS Foundation Trust

Case 24 • 85F; Breast mass

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

DIAGNOSIS • Metaplastic carcinoma

The Christie NHS Foundation Trust

Case 26 • 34F; Thigh mass • (Microscope)

The Christie NHS Foundation Trust

• Positive for S100,EMA, Chr, Synap

The Christie NHS Foundation Trust

Diagnosis • Extraskeletal myxoid chondrosarcoma (EMC) • • • • •

M=F Extremities Slow growing Multinodular Most low grade

• • •

CD117 +ve in 30% Loss of INI-1(cases with rhabdoid morphology) >90% have NR4A3 gene rearrangement: fused with either EWSR1 at 22q12.2 (75%) or TAF15 at 17q12. Variant translocations (TCF12-NR4A3 and TFG-NR4A3) seen in others

• D/D: MFS, Myxoid Liposarcoma, Myoepithelial tumour, carcinoma The Christie NHS Foundation Trust

Case 13 • 79M; Perineal lesion

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

• • • • • •

Positive for: CD34 SMA Desmin ER and PR Associated loss of RB1 expression

The Christie NHS Foundation Trust

DIAGNOSIS

The Christie NHS Foundation Trust

Cellular Angiofibroma • Partial or complete losses of chromosome 13 (including the RB1 locus) and/or chromosome 16 found in cellular angiofibroma, spindle cell / pleomorphic lipoma and myofibroblastoma

The Christie NHS Foundation Trust

Soft Tissue Tumours of the Genital Tract • • • •

AA Smooth muscle tumours Fibroepithelial polyp (cellular) Angiomyofibroblastoma

The Christie NHS Foundation Trust

Case 2 • 40M; Thigh lesion

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

DIAGNOSIS

The Christie NHS Foundation Trust

Intramuscular Myxoma • Involves deep soft tissues - large muscles of the thigh, shoulder, buttock, and upper arm • Cytologically bland, hypocellular lesion • Composed of uniform spindle to stellate-shaped cells • Subset of tumours show hypercellular areas • Positive for CD34 and rarely for SMA • Desmin and S100 are negative • •

Activating point mutation in GNAS (exons 8 and 9) detected in > 90% of sporadic intramuscular and cellular myxomas May occur in combination with fibrous dysplasia (Mazabraud syndrome)resulting from postzygotic activating somatic mutations in the GNAS gene

The Christie NHS Foundation Trust

D/D • • • • • •

Aggressive angiomyxoma Myxoid NF LGFS Myxoid liposarc Low grade myxofibrosarcoma Intramuscular myxoma

The Christie NHS Foundation Trust

Case 5 • 61M; Mass adherent to stomach

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

DOG 1.1 The Christie NHS Foundation Trust

Case 15 • 20F; Gastric Mass

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

IHC • Positive for CD34, CD117, DOG1.1, SMA and hcaldesmon

• DOG1 The Christie NHS Foundation Trust

DIAGNOSIS • GIST

The Christie NHS Foundation Trust

Case 29 • 29F; Parotid mass

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

DIAGNOSIS • Spindle cell lipoma

The Christie NHS Foundation Trust

Case 9 • 64F; Shoulder mass

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

DIAGNOSIS

The Christie NHS Foundation Trust

Spindle Cell Lipoma (SCL) (1)

• Usually involve head, neck and shoulder regions of middle aged men • Present as a painless, mobile, solitary mass within the superficial soft tissues (often with a long history) • Rare cases described elsewhere (limbs, oral cavity, breast, larynx, spermatic cord etc) and also in the dermis • Very rarely multiple and familial • Usually less than 5.0 cms in diameter & circumscribed • Oval or discoid, yellowish or greyish-white, may be mucoid

The Christie NHS Foundation Trust

SCL(3) • IHC: spindle cells strongly +ve for CD34. Also CD10, Bcl2+ve(50%) Adipocytes + ve for S100 protein AR positivity in both spindle and adipocytic cells in almost all cases (Syed S et al. Arch. Pathol.

Lab. Med. 2008;132;81-3)

The Christie NHS Foundation Trust

Variants of SCL • Myxoid • Pseudoangiomatous • Angiomatous (haemangiopericytic, cavernous/capillary or curvilinear +/- perivascular hyalinization) • Low fat or fat free (Billings SD & Folpe AL Am. J. Dermatopathol.

2007;29;437-442) • Fibrous/collagenous • Plexiform • Composite • ? Inflammatory

The Christie NHS Foundation Trust

D/D of Spindle Cell Lipoma • Spindle cell liposarcoma and ALT (those with pleomorphic lipoma component) • Dendritic fibromyxolipoma (Suster S. et al. Ann. Diagn.

Pathol. 1998;2:111-20)

• • • • •

Peripheral nerve sheath tumour Mammary type myofibroblastoma Cellular angiofibroma Myxoid liposarcoma ( myxoid SCL) Lipomatous hemangiopericytoma

The Christie NHS Foundation Trust

Myxoid SCL vs. Myxoid Liposarcoma(MLS) • Difference in sites (neck, upper back and shoulder for SCL; extremities and trunk for MLS) • Subcutaneous (SCL) vs deep (MLS) • Cells are spindly in SCL; round, oval or stellate in MLS. Also lipoblasts in MLS • Prominent chicken wire vascularity in MLS

The Christie NHS Foundation Trust

Myxoid SCL vs Myxoid Liposarcoma(MLS) - cont • Microcystic lymphangioma-like areas in many MLS; not seen in SCL • CD34 more strongly and diffusely positive in SCL; only a small number of CD34 +ve cells in MLS (Suster S, Fisher C. Am. J. Surg. Pathol.

1997;21;195-200) • CHOP/DDIT3 and FUS or EWS gene fusion t(12;16) or t(12;22) in MLS

The Christie NHS Foundation Trust

MLS

The Christie NHS Foundation Trust

PL

The Christie NHS Foundation Trust

Case 28 • 48M; Retroperitoneal mass

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

DIAGNOSIS • Atypical spindle cell lipomatous tumour (previously called spindle cell liposarcoma)

The Christie NHS Foundation Trust

Mostly Superficial Myxoid Soft Tissue Tumours • • • • • • • • • •

“Ganglion” Myxoid NF Myxoid Nodular Fasciitis Myxoid Spindle cell lipoma Myxoid Neurothekeoma Sup. Angiomyxoma OFMT Myoepithelioma Agg. Angiomyxoma Digital myxoma

• Myxofibrosarcoma • Myxoid DFSP

The Christie NHS Foundation Trust

Mostly Deep Myxoid Soft Tissue Tumours • Intramuscular myxoma • Cellular myxoma • Juxta-articular myxoma

• • • • • •

Myxoid Liposarcoma EMC LGFS Chordoma Myxoid MPNST Myxopapillary Ependymoma • Myxoid Leiomyosarcoma • Synovial sarcoma • Solitary Fibrous Tumour The Christie NHS Foundation Trust

Case 30 • 68M; Mediastinal mass

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

DIAGNOSIS • Dedifferentiated Liposarcoma

The Christie NHS Foundation Trust

Dedifferentiated Liposarcoma Morphologically variable: •Undifferentiated pleo. sarcoma-like •Myxofibrosarcoma-like •Infl. myofibroblastic tumour-like

•Neural-like or meningothelial-like whorls seen in some cases •Pleo. liposarcoma-like

•Low grade dedifferentiation

Coindre 2003, 2004; Binh 2005, 2007; Lucas, 2010; 2010 The Mariño-Enríquez, Christie NHS Foundation Trust

Heterologous differentiation (~10% of cases):

Osteosarcomatous

Rhabdomyosarcomatous

Chondrosarcomatous

The Christie NHS Foundation Trust

Leiomyosarcomatous

Case 14 • 66F; Retroperitoneal mass

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

CD34

DOG 1.1

CD117

h-Caldesmon The Christie NHS Foundation Trust

DIAGNOSIS • GIST

The Christie NHS Foundation Trust

GIST

The Christie NHS Foundation Trust

GIST

The Christie NHS Foundation Trust

Rhabdomyosarcomatous differentiation in GIST post tyrosine kinase inhibitor therapy

The Christie NHS Foundation Trust

GIST Immunohistochemistry • • • • • • • • • •

DOG1 (99%) CD117 (95%) CD34 (70%) PKC theta (96%) SMA (30-40%) S100 (5%) h-caldesmon (80%) Desmin (<1%) CK (<1%) MUC4 -ve The Christie NHS Foundation Trust

DOG1 positivity in LGFMS Thway K et al. Int J Surg Pathol. 23(6):454-60

• 5/11 showed varying amounts of DOG1 expression, ranging from weakly in approximately 5% of cells to strongly in up to 100% of cells

The Christie NHS Foundation Trust

Features of Lipoblasts • Cytoplasmic vacuoles (one or more): large round empty • Nucleus indented

The Christie NHS Foundation Trust

Lipoblasts

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

GIST

EMC

CARCINOMA

MYXOFIBROSARCOMA

LMS

CHORDOMA

The Christie NHS Foundation Trust

Case 18# • 56 Female – parametrial mass

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

• h-caldesmon

• SMA • Melan-A The Christie NHS Foundation Trust

DIAGNOSIS

The Christie NHS Foundation Trust

Angiomyolipoma • PEComas -

AML Clear cell “sugar” tumour of the lungs LAM PEST(primary extrapulmonary sugar tumour) Clear cell myomelanocytic tumour

The Christie NHS Foundation Trust

PEComas • Ass. With tuberous sclerosis complex (– usually multiple AMLs) • Criteria for malignancy - >/=70% atypical epithelioid cells - >/=2mitoses per 10HPFs - Atypical mitotic figures - necrosis

The Christie NHS Foundation Trust

Case 3 • 61M; sacral tumour

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust

Galectin

CK

S100 The Christie NHS Foundation Trust

DIAGNOSIS

The Christie NHS Foundation Trust

Chordoma • 50% sacrococcygeal region • 35% base of skull Variants Chondroid Chordoma Dedifferentiated Chordoma

The Christie NHS Foundation Trust

D/D • Chondrosarcoma • Myxopapillary ependymoma • Parachordoma

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust